Mercer Global Advisors Inc. ADV Acquires 749 Shares of Encompass Health Co. (NYSE:EHC)

Mercer Global Advisors Inc. ADV raised its stake in Encompass Health Co. (NYSE:EHC) by 4.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,452 shares of the company’s stock after purchasing an additional 749 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Encompass Health were worth $1,612,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of EHC. Miracle Mile Advisors LLC raised its stake in Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock worth $354,000 after purchasing an additional 112 shares in the last quarter. US Bancorp DE lifted its stake in shares of Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company’s stock worth $127,000 after acquiring an additional 121 shares during the period. Signaturefd LLC grew its holdings in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after acquiring an additional 125 shares during the period. CBIZ Investment Advisory Services LLC boosted its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the period. 97.25% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays raised their price objective on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a report on Friday, April 25th. Truist Financial reissued a “buy” rating and set a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. KeyCorp raised their target price on shares of Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, April 25th. Finally, UBS Group upped their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a “buy” rating in a report on Monday, April 28th. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average price target of $120.86.

Encompass Health Stock Performance

Shares of EHC opened at $116.13 on Friday. The firm has a market cap of $11.70 billion, a PE ratio of 26.04, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The stock has a fifty day moving average price of $103.08 and a 200-day moving average price of $99.78. Encompass Health Co. has a 12 month low of $82.74 and a 12 month high of $118.27.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business’s revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the company earned $1.12 EPS. Equities research analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.59%. Encompass Health’s dividend payout ratio (DPR) is presently 14.05%.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,321 shares of company stock valued at $2,142,452. Corporate insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.